Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study. (Record no. 30496042)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01845 a2200577 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518080434.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202012s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1744-764X |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1080/14740338.2020.1713090 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Wang, Wen |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20201215 |
| 245 00 - TITLE STATEMENT | |
| Title | Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Expert opinion on drug safety |
| Date of publication, distribution, etc. | Mar 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 339-347 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Comparative Study; Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anti-Bacterial Agents |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Blood Coagulation Disorders |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Blood Platelets |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cefoperazone |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ceftazidime |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Therapy, Combination |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hemorrhage |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prothrombin Time |
| General subdivision | statistics & numerical data |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sulbactam |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tazobactam |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Yanmei |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yu, Chuan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tan, Jing |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Xiong, Weiyi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dong, Duo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Li, Sheyu |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhang, Rui |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Li, Jijie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wu, Yu |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zong, Zhiyong |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Su, Na |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zou, Kang |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wu, Guizhi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sun, Xin |
| 773 0# - HOST ITEM ENTRY | |
| Title | Expert opinion on drug safety |
| Related parts | vol. 19 |
| -- | no. 3 |
| -- | p. 339-347 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1080/14740338.2020.1713090">https://doi.org/10.1080/14740338.2020.1713090</a> |
| Public note | Available from publisher's website |
No items available.